Silvercrest Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,576
Closed -$448K 914
2024
Q1
$448K Hold
6,576
﹤0.01% 728
2023
Q4
$412K Buy
+6,576
New +$412K ﹤0.01% 703